share_log

BTIG Initiates Coverage On IDEAYA Biosciences With Buy Rating, Announces Price Target of $55

BTIG Initiates Coverage On IDEAYA Biosciences With Buy Rating, Announces Price Target of $55

BTIG以買入評級啓動對IDEAYA Biosciences的報道,宣佈目標股價爲55美元
Moomoo 24/7 ·  03/08 09:15

BTIG analyst Justin Zelin initiates coverage on IDEAYA Biosciences (NASDAQ:IDYA) with a Buy rating and announces Price Target of $55.

BTIG分析師賈斯汀·澤林以買入評級啓動了對IDEAYA Biosciences(納斯達克股票代碼:IDYA)的報道,並宣佈目標股價爲55美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論